Statistics from Altmetric.com
The first randomised controlled trial of emollient bath additives for children with eczema found that they added no clinically-important benefits, compared with usual care.1
The NHS in England spends an estimated £23 million per year on bath-additive products that are designed to leave a protective oily layer on the skin.1 This pragmatic, open-label trial investigated the clinical and cost effectiveness of bath-additive products and included 483 children (aged 1 to 11 years) who fulfilled the UK diagnostic criteria for atopic dermatitis. Patients were …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.